AstraZeneca unveiled a campaign-‘Beyond Sugar’, a three-year patient awareness program developed to benefit over 1 crore people living with diabetes across the country. This initiative will empower patients/caregivers to have conversations around diabetes and make informed decisions about the management of the disease.
“The purpose of this collaboration between AstraZeneca and RSSDI is to leverage technology to connect the doctor and the patient to provide authentic information. The partnership will go a long way in supporting patient-centric digital awareness campaigns and programs to raise awareness about diabetes and its complications so that they can act early to manage or even prevent the complications,” said Dr. Anil Kukreja, Vice President – Medical Affairs & Regulatory, AstraZeneca India.
While speaking on the digital initiative, Dr Kukreja told ETHealthworld, “Face-to-face meetings do have their unique advantages of connecting but the kind of reach which we can have through digital medium and the education you can drive through digital have their own advantages. We have seen digital initiatives getting a lot of traction.”
“In the COVID era, this digitally-powered initiative will also empower patients/caregivers to have better conversations with their doctors about the disease and make informed decisions in the management of diabetes. All this will culminate towards shifting from the glucose centric management approach towards a holistic and an early Cardio-Renal focused management of type 2 diabetes, ” said Dr. Banshi Saboo, President- RSSDI and Organising Chairman 2020.
“We are mainly looking from the heart point of view as 2/3rd of our diabetic patients develop cardiovascular and kidney-related complications, which are very much neglected. If patients are well educated and screened early, we can prevent these complications,” he concluded.